Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
about
Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@en
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@nl
type
label
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@en
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@nl
prefLabel
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@en
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@nl
P2093
P2860
P1433
P1476
Apatinib, a novel tyrosine kin ...... nd synergizes with Paclitaxel.
@en
P2093
P2860
P356
10.1080/15384101.2018.1471315
P577
2018-06-09T00:00:00Z